Robert P Schleimer, MD
Disclosures: grant money paid to institution-current-National Institutes of Health|Consulting Fee-current-Allakos|Consultant, stock/stock options not yet valued-current-BioMarck|Consulting Fee-current-Sanofi-Aventis|Consulting Fee-current-Genentech, Inc.|Consultant, stock/stock options not yet valued-current-Exicure Inc|Consultant, stock/stock options not yet valued-current-Aqualung Therapeutics Corp|Consulting Fee-current-ActoBio Therapeutics|Consulting Fee-current-Lyra Therapeutics
No Bio Available.